↑Zimonjic DB, Alimandi M, Miki T, Popescu NC, Kraus MH(Mar 1995).“Localization of the human HER4/erbB-4 gene to chromosome 2”.Oncogene10(6): 1235–7.PMID7700649.
↑Sardi SP, Murtie J, Koirala S, Patten BA, Corfas G(Oct 2006).“Presenilin-dependent ErbB4 nuclear signaling regulates the timing of astrogenesis in the developing brain”.Cell127(1): 185–97.doi:10.1016/j.cell.2006.07.037.PMID17018285.
↑Silberberg G, Darvasi A, Pinkas-Kramarski R, Navon R(Mar 2006).“The involvement of ErbB4 with schizophrenia: association and expression studies”.American Journal of Medical Genetics Part B141B(2): 142–8.doi:10.1002/ajmg.b.30275.PMID16402353.
↑Huang YZ, Won S, Ali DW, Wang Q, Tanowitz M, Du QS, Pelkey KA, Yang DJ, Xiong WC, Salter MW, Mei L(May 2000).“Regulation of neuregulin signaling by PSD-95 interacting with ErbB4 at CNS synapses”.Neuron26(2): 443–55.doi:10.1016/S0896-6273(00)81176-9.PMID10839362.
↑Omerovic J, Puggioni EM, Napoletano S, Visco V, Fraioli R, Frati L, Gulino A, Alimandi M(Apr 2004).“Ligand-regulated association of ErbB-4 to the transcriptional co-activator YAP65 controls transcription at the nuclear level”.Experimental Cell Research294(2): 469–79.doi:10.1016/j.yexcr.2003.12.002.PMID15023535.
Culouscou JM, Plowman GD, Carlton GW, Green JM, Shoyab M(Sep 1993).“Characterization of a breast cancer cell differentiation factor that specifically activates the HER4/p180erbB4 receptor”.The Journal of Biological Chemistry268(25): 18407–10.doi:10.1016/S0021-9258(17)46636-1.PMID7689552.
Barbacci EG, Guarino BC, Stroh JG, Singleton DH, Rosnack KJ, Moyer JD, Andrews GC(Apr 1995).“The structural basis for the specificity of epidermal growth factor and heregulin binding”.The Journal of Biological Chemistry270(16): 9585–9.doi:10.1074/jbc.270.16.9585.PMID7721889.
Carraway KL, Weber JL, Unger MJ, Ledesma J, Yu N, Gassmann M, Lai C(May 1997).“Neuregulin-2, a new ligand of ErbB3/ErbB4-receptor tyrosine kinases”.Nature387(6632): 512–6.Bibcode:1997Natur.387R.512C.doi:10.1038/387512a0.PMID9168115.
Chow NH, Liu HS, Yang HB, Chan SH, Su IJ(Jun 1997).“Expression patterns of erbB receptor family in normal urothelium and transitional cell carcinoma. An immunohistochemical study”.Virchows Archiv430(6): 461–6.doi:10.1007/s004280050056.PMID9230911.
Elenius K, Corfas G, Paul S, Choi CJ, Rio C, Plowman GD, Klagsbrun M(Oct 1997).“A novel juxtamembrane domain isoform of HER4/ErbB4. Isoform-specific tissue distribution and differential processing in response to phorbol ester”.The Journal of Biological Chemistry272(42): 26761–8.doi:10.1074/jbc.272.42.26761.PMID9334263.
Komurasaki T, Toyoda H, Uchida D, Morimoto S(1997).“Epiregulin binds to epidermal growth factor receptor and ErbB-4 and induces tyrosine phosphorylation of epidermal growth factor receptor, ErbB-2, ErbB-3 and ErbB-4”.Oncogene15(23): 2841–8.doi:10.1038/sj.onc.1201458.PMID9419975.
Fiddes RJ, Campbell DH, Janes PW, Sivertsen SP, Sasaki H, Wallasch C, Daly RJ(Mar 1998).“Analysis of Grb7 recruitment by heregulin-activated erbB receptors reveals a novel target selectivity for erbB3”.The Journal of Biological Chemistry273(13): 7717–24.doi:10.1074/jbc.273.13.7717.PMID9516479.
Jones JT, Ballinger MD, Pisacane PI, Lofgren JA, Fitzpatrick VD, Fairbrother WJ, Wells JA, Sliwkowski MX(May 1998).“Binding interaction of the heregulinbeta egf domain with ErbB3 and ErbB4 receptors assessed by alanine scanning mutagenesis”.The Journal of Biological Chemistry273(19): 11667–74.doi:10.1074/jbc.273.19.11667.PMID9565587.
Harari D, Tzahar E, Romano J, Shelly M, Pierce JH, Andrews GC, Yarden Y(Apr 1999).“Neuregulin-4: a novel growth factor that acts through the ErbB-4 receptor tyrosine kinase”.Oncogene18(17): 2681–9.doi:10.1038/sj.onc.1202631.PMID10348342.
外部リンク
Overview of all the structural information available in the PDB for UniProt: Q15303 (Receptor tyrosine-protein kinase erbB-4) at the PDBe-KB.